89 related articles for article (PubMed ID: 17191009)
61. Trends and level of control of hypertension among adults attending an ambulatory HIV clinic in Kampala, Uganda: a retrospective study.
Kalyesubula R; Kayongo A; Semitala FC; Muhanguzi A; Katantazi N; Ayers D; Forrest JI; Mills EJ
BMJ Glob Health; 2016; 1(3):e000055. PubMed ID: 28588953
[TBL] [Abstract][Full Text] [Related]
62. Early age at first sexual intercourse and early pregnancy are risk factors for cervical cancer in developing countries.
Louie KS; de Sanjose S; Diaz M; Castellsagué X; Herrero R; Meijer CJ; Shah K; Franceschi S; Muñoz N; Bosch FX;
Br J Cancer; 2009 Apr; 100(7):1191-7. PubMed ID: 19277042
[TBL] [Abstract][Full Text] [Related]
63. Epidemiology and survival outcomes of HIV-associated cervical cancer in Nigeria.
Musa J; Kocherginsky M; Magaji FA; Maryam AJ; Asufi J; Nenrot D; Burdett K; Katam N; Christian EN; Palanisamy N; Odukoya O; Silas OA; Abdulkareem F; Akpa P; Badmos K; Imade GE; Akanmu AS; Gursel DB; Zheng Y; Joyce BT; Achenbach CJ; Sagay AS; Anorlu R; Wei JJ; Ogunsola F; Murphy RL; Hou L; Simon MA
Infect Agent Cancer; 2023 Nov; 18(1):68. PubMed ID: 37915091
[TBL] [Abstract][Full Text] [Related]
64. Epidemiology and Survival outcomes of HIV-associated cervical cancer in Nigeria.
Musa J; Kocherginsky M; Magaji FA; Maryam AJ; Asufi J; Nenrot D; Burdett K; Katam N; Christian EN; Palanisamy N; Odukoya O; Silas OA; Abdulkareem F; Akpa P; Badmos K; Imade GE; Akanmu AS; Gursel DB; Zheng Y; Joyce BT; Achenbach CJ; Sagay AS; Anorlu R; Wei JJ; Ogunsola F; Murphy RL; Hou L; Simon MA
medRxiv; 2023 Aug; ():. PubMed ID: 37609183
[TBL] [Abstract][Full Text] [Related]
65. Cancer in Kampala.
KNOWELDEN J
Proc R Soc Med; 1957 Apr; 50(4):249-50. PubMed ID: 13431875
[No Abstract] [Full Text] [Related]
66. Implementation and Operational Research: Age Distribution and Determinants of Invasive Cervical Cancer in a "Screen-and-Treat" Program Integrated With HIV/AIDS Care in Zambia.
Kapambwe S; Sahasrabuddhe VV; Blevins M; Mwanahamuntu MH; Mudenda V; Shepherd BE; Chibwesha CJ; Pfaendler KS; Hicks ML; Vermund SH; Stringer JS; Parham GP
J Acquir Immune Defic Syndr; 2015 Sep; 70(1):e20-6. PubMed ID: 26322673
[TBL] [Abstract][Full Text] [Related]
67. The association between HIV infection, antiretroviral therapy and cervical squamous intraepithelial lesions in South Western Nigerian women.
Ezechi OC; Pettersson KO; Okolo CA; Ujah IA; Ostergren PO
PLoS One; 2014; 9(5):e97150. PubMed ID: 24809726
[TBL] [Abstract][Full Text] [Related]
68. The impact of human immunodeficiency virus infection on cervical preinvasive and invasive neoplasia in South Africa.
van Bogaert LJ
Ecancermedicalscience; 2013; 7():334. PubMed ID: 23882298
[TBL] [Abstract][Full Text] [Related]
69. Universal routine HPV vaccination for young girls in Uganda: a review of opportunities and potential obstacles.
Banura C; Mirembe FM; Katahoire AR; Namujju PB; Mbidde EK
Infect Agent Cancer; 2012 Sep; 7(1):24. PubMed ID: 22950658
[TBL] [Abstract][Full Text] [Related]
70. Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings.
Memiah P; Mbuthia W; Kiiru G; Agbor S; Odhiambo F; Ojoo S; Biadgilign S
AIDS Res Treat; 2012; 2012():953743. PubMed ID: 22548156
[TBL] [Abstract][Full Text] [Related]
71. HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study.
Odida M; Sandin S; Mirembe F; Kleter B; Quint W; Weiderpass E
Infect Agent Cancer; 2011 Jun; 6(1):8. PubMed ID: 21702999
[TBL] [Abstract][Full Text] [Related]
72. Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda.
Mutyaba T; Mirembe F; Sandin S; Weiderpass E
Reprod Health; 2010 May; 7():4. PubMed ID: 20459733
[TBL] [Abstract][Full Text] [Related]
73. The challenge of AIDS-related malignancies in sub-Saharan Africa.
Sasco AJ; Jaquet A; Boidin E; Ekouevi DK; Thouillot F; Lemabec T; Forstin MA; Renaudier P; N'dom P; Malvy D; Dabis F
PLoS One; 2010 Jan; 5(1):e8621. PubMed ID: 20066157
[TBL] [Abstract][Full Text] [Related]
74. Association between invasive cancer of the cervix and HIV-1 infection in Tanzania: the need for dual screening.
Kahesa C; Mwaiselage J; Wabinga HR; Ngoma T; Kalyango JN; Karamagi CA
BMC Public Health; 2008 Jul; 8():262. PubMed ID: 18664298
[TBL] [Abstract][Full Text] [Related]
75. HIV infection among Uganda women with cervical cancer: a retrospective study.
Sekirime WK; Gray R
Gynecol Obstet Invest; 2007; 63(4):222-8. PubMed ID: 17191009
[TBL] [Abstract][Full Text] [Related]
76. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.
La Ruche G; Ramon R; Mensah-Ado I; Bergeron C; Diomandé M; Sylla-Koko F; Ehouman A; Touré-Coulibaly K; Welffens-Ekra C; Dabis F
Cancer; 1998 Jun; 82(12):2401-8. PubMed ID: 9635533
[TBL] [Abstract][Full Text] [Related]
77. A case-control study of cancer of the uterine cervix in Uganda.
Newton R; Ziegler J; Casabonne D; Beral V; Mbidde E; Carpenter L; Maxwell Parkin D; Wabinga H; Mbulaiteye S; Jaffe H;
Eur J Cancer Prev; 2007 Dec; 16(6):555-8. PubMed ID: 18090129
[TBL] [Abstract][Full Text] [Related]
78. Human immunodeficiency virus infection and invasive cervical cancer in South Africa.
Lomalisa P; Smith T; Guidozzi F
Gynecol Oncol; 2000 Jun; 77(3):460-3. PubMed ID: 10831360
[TBL] [Abstract][Full Text] [Related]
79. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
80. Squamous cell cervical lesions in women with and without AIDS. Biochemical risk factors, prevention, and policy.
Lovejoy NC; Anastasi JK
Cancer Nurs; 1994 Aug; 17(4):294-307. PubMed ID: 7954377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
